Eikon Therapeutics. Every tracked FinTwit mention of $EIKN, newest first. 6 mentions since the first on Feb 2, 2026. See the price chart.
February 2026 · 6 mentions
Feb 6
Jacob Plieth — @SamFazeli8 15% below the issue price, and 55% below the average at which VCs invested. I think the IPO window does indeed remain putative $EIKN↗
Jacob Plieth — $EIKN prices at $18/share, to raise $381m at a $972m market cap. Here's @ApexOnco on what this IPO tells us: https://t.co/OYpmTI21qI↗
Feb 3
Jacob Plieth — @charlene_liao @garbageman1985 I'm not sure there's any fund with a direct ownership link to $MRK here. $EIKN https://t.co/qrD8vzxKhI↗
Feb 3
Jacob Plieth — @charlene_liao @garbageman1985 $EIKN https://t.co/FPN0YaSx04↗
Feb 2
Jacob Plieth — $EIKN share price averaged over private financings, vs at expected IPO. Normally there's a (substantial) step up when companies float. Not in this case https://t.co/Keb3FHRzcL↗